Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Doxium (calcium dobesilate) in early stages of diabetic retinopathy
2017-000250-19Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of calcium dobesilate in diabetic retinopathy (DR) and diabetic macular edema (DME), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Change in retinal thickness. Started Apr 2017; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
diabetic retinopathy (DR)diabetic macular edema (DME)
Beyond the preview
Go deeper on 2017-000250-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000250-19.